Astrana Health [ASTH] vs HCA Healthcare [HCA] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 21 vital metrics comparison: Astrana Health Inc. wins in 7 metrics, HCA Healthcare Inc. wins in 13 metrics, with 0 ties. HCA Healthcare Inc. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Astrana Health Inc. | HCA Healthcare Inc. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 73.30 | 16.86 | HCA Healthcare Inc. |
| Price-to-Book Ratio | 2.12 | -38.44 | Astrana Health Inc. |
| Debt-to-Equity Ratio | 193.10 | -17.57 | Astrana Health Inc. |
| PEG Ratio | -0.41 | 0.37 | HCA Healthcare Inc. |
| EV/EBITDA | 14.57 | 10.08 | HCA Healthcare Inc. |
| Profit Margin (TTM) | 0.71% | 8.97% | HCA Healthcare Inc. |
| Operating Margin (TTM) | 1.85% | 16.29% | HCA Healthcare Inc. |
| EBITDA Margin (TTM) | 1.85% | 16.29% | HCA Healthcare Inc. |
| Return on Equity | 4.49% | -244.82% | Astrana Health Inc. |
| Return on Assets (TTM) | 3.43% | 12.44% | HCA Healthcare Inc. |
| Free Cash Flow (TTM) | $104.49M | $7.69B | HCA Healthcare Inc. |
| Dividend Yield | N/A | 0.59% | N/A |
| 1-Year Return | 51.75% | -0.75% | Astrana Health Inc. |
| Price-to-Sales Ratio (TTM) | 0.59 | 1.39 | Astrana Health Inc. |
| Enterprise Value | $2.10B | $156.18B | HCA Healthcare Inc. |
| EV/Revenue Ratio | 0.66 | 2.07 | Astrana Health Inc. |
| Gross Profit Margin (TTM) | 10.00% | 41.90% | HCA Healthcare Inc. |
| Revenue per Share (TTM) | $65 | $320 | HCA Healthcare Inc. |
| Earnings per Share (Diluted) | $0.46 | $27.94 | HCA Healthcare Inc. |
| Beta (Stock Volatility) | 0.77 | 1.37 | Astrana Health Inc. |
| Short % of Float | 8.35% | 2.45% | HCA Healthcare Inc. |
Astrana Health Inc. vs HCA Healthcare Inc. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Astrana Health Inc. | -0.65% | -4.23% | 5.52% | 40.24% | 61.74% | 46.35% |
| HCA Healthcare Inc. | -1.10% | -6.38% | -14.00% | -31.06% | -26.57% | -21.90% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Astrana Health Inc. | 51.75% | 11.50% | 1.87% | 585.25% | 637.65% | 637.65% |
| HCA Healthcare Inc. | -0.75% | 38.02% | 77.08% | 384.44% | 1,008.79% | 1,116.39% |
Performance & Financial Health Analysis: Astrana Health Inc. vs HCA Healthcare Inc.
| Metric | ASTH | HCA |
|---|---|---|
| Market Information | ||
| Market Cap | $1.88B | $106.00B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 497,178 | 795,641 |
| 90 Day Avg. Volume | 435,283 | 974,074 |
| Last Close | $36.67 | $363.30 |
| 52 Week Range | $18.08 - $39.93 | $330.00 - $556.52 |
| % from 52W High | -8.16% | -34.72% |
| All-Time High | $133.23 (Nov 15, 2021) | $556.52 (Mar 12, 2026) |
| % from All-Time High | -72.48% | -34.72% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.43% | 0.07% |
| Quarterly Earnings Growth | 0.43% | 0.31% |
| Financial Health | ||
| Profit Margin (TTM) | 0.01% | 0.09% |
| Operating Margin (TTM) | 0.02% | 0.16% |
| Return on Equity (TTM) | 0.04% | -2.45% |
| Debt to Equity (MRQ) | 193.10 | -17.57 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $15.94 | $-26.83 |
| Cash per Share (MRQ) | $8.68 | $5.11 |
| Operating Cash Flow (TTM) | $114.60M | $12.64B |
| Levered Free Cash Flow (TTM) | $227.95M | $5.82B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.59% |
| Last 12-Month Dividend | N/A | $2.94 |
Valuation & Enterprise Metrics Analysis: Astrana Health Inc. vs HCA Healthcare Inc.
| Metric | ASTH (Apr 26, 2026) | HCA (Apr 23, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 73.30 | 16.86 |
| Forward P/E | 10.50 | 14.13 |
| PEG Ratio | -0.41 | 0.37 |
| Price to Sales (TTM) | 0.59 | 1.39 |
| Price to Book (MRQ) | 2.12 | -38.44 |
| Market Capitalization | ||
| Market Capitalization | $1.88B | $106.00B |
| Enterprise Value | $2.10B | $156.18B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.66 | 2.07 |
| Enterprise to EBITDA | 14.57 | 10.08 |
| Risk & Other Metrics | ||
| Beta | 0.77 | 1.37 |
| Book Value per Share (MRQ) | $15.94 | $-26.83 |
Financial Statements Comparison: Astrana Health Inc. vs HCA Healthcare Inc.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | ASTH (2025) | HCA (2025) |
|---|---|---|
| Revenue/Sales | 3.18B | 75.60B |
| Cost of Goods Sold | 2.84B | 44.23B |
| COGS % of Revenue | 89.3% | 58.5% |
| Gross Profit | 341.53M | 31.37B |
| Gross Margin | 10.7% | 41.5% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | 78.53M | 11.97B |
| Operating Margin | 2.5% | 15.8% |
| EBITDA | 135.35M | 15.57B |
| EBITDA Margin | 4.3% | 20.6% |
| Pre-Tax Income | 39.61M | 9.83B |
| Pre-Tax Income % of Revenue | 1.2% | 13.0% |
| Income Tax | 15.53M | 2.05B |
| Income Tax % of Revenue | 0.5% | 2.7% |
| Net Income (Profit) | 24.08M | 7.78B |
| Profit Margin | 0.8% | 10.3% |
Balance Sheet & Liquidity Metrics
| Metric | ASTH (2025) | HCA (2025) |
|---|---|---|
| Cash & Equivalents | 429.47M | 1.04B |
| Total Current Assets | 863.31M | 15.78B |
| Total Current Assets % of Revenue | 27.1% | 20.9% |
| Total Current Liabilities | 615.27M | 16.35B |
| Total Current Liabilities % of Revenue | 19.3% | 21.6% |
| Long-Term Debt | 1.02B | 43.46B |
| Long-Term Debt % of Revenue | 32.1% | 57.5% |
| Total Shareholders Equity | 558.33M | -2.77B |
| Retained Earnings | 308.38M | -5.72B |
| Retained Earnings % of Revenue | 9.7% | -7.6% |
| Property, Plant & Equipment | 35.74M | 39.12B |
Cash Flow Statement Comparison
| Metric | ASTH (2025) | HCA (2025) |
|---|---|---|
| Operating Cash Flow | 109.88M | 12.01B |
| Operating Cash Flow % of Revenue | 3.5% | 15.9% |
| Capital Expenditures | -10.11M | -4.94B |
| Free Cash Flow | 104.49M | 7.69B |
| FCF Margin | 3.3% | 10.2% |
| Debt Repayment | -495.29M | -7.39B |
| Common Stock Repurchase | -15.43M | -10.07B |
Short Interest & Institutional Ownership Analysis
| Metric | ASTH | HCA |
|---|---|---|
| Shares Short | 2.68M | 3.63M |
| Short Ratio | 6.86 | 3.37 |
| Short % of Float | 8.35% | 2.45% |
| Shares Outstanding | 48.89M | 224.61M |
| Float Shares | 44.36M | 151.19M |
| % Held by Insiders | 20.32% | 16.16% |
| % Held by Institutions | 52.52% | 78.70% |
| % Held by Public | 27.16% | 5.14% |
Dividend Analysis & Yield Comparison: Astrana Health Inc. vs HCA Healthcare Inc.
| Metric | ASTH | HCA |
|---|---|---|
| Last 12-Month Dividend | N/A | $2.94 |
| Last 12-Month Dividend Yield | N/A | 0.59% |
| 3-Year Avg Annual Dividend | N/A | $2.70 |
| 3-Year Avg Dividend Yield | N/A | 0.19% |
| 3-Year Total Dividends | N/A | $8.10 |
| Ex-Dividend Date | N/A | Mar 17, 2026 |